• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Pharma
    • Oncology
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Supply Chain
    • AI and Machine Learning
  • Awards
    • Outsourcing Awards
    • Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Pharma
    • Oncology
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Supply Chain
    • AI and Machine Learning
  • Awards
    • Outsourcing Awards
    • Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us

Germany

Graphic image of two hands shaking with employeesexecutives on the forearms of each shaking hand
Manufacturing

Gerresheimer sheds pair of units in deal valued at €1.5B

Gerresheimer sold two of its units to the private equity group Apax Partners in a deal valued at €1.5 billion ($1.73 billion).
Joseph Keenan Aug 3, 2026 9:40am
EU pharma EU biopharma EU pharmaceutical industry European Union Euros

Germany approves controversial healthcare reform package

Jul 13, 2026 10:40am
German flag

Germany scraps variable discount plan meant to cut costs: report

Jun 15, 2026 3:30pm
European Union flag

5 EU countries call for 'unity' in Europe's drug pricing approach

Jun 11, 2026 11:27am
Albert Bourla

Pfizer CEO Bourla reconsiders future German investments: Reuters

Jun 10, 2026 11:26am
Berlin Germany Brandenburg Gate

Lilly, Boehringer slash investment plans in Germany

Jun 3, 2026 3:10pm

Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Biotech
    • Fierce Healthcare
    • Fierce Pharma
  • Our Events
    • Life Sciences Events
©2026 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings